Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESA LABORATORIES INC /CO/ Director's Dealing 2021

Dec 15, 2021

33153_dirs_2021-12-15_96f93230-3b32-427b-bb79-80027181aa52.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2021-12-14

Reporting Person: Archbold Brian David (SVP Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-14 Common Stock M 210 $142.4 Acquired 364 Direct
2021-12-14 Common Stock M 532 $203.54 Acquired 896 Direct
2021-12-14 Common Stock M 917 $226.72 Acquired 1813 Direct
2021-12-14 Common Stock S 1659 $325.02 Disposed 154 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-14 Non Qualified Stock Option $142 X 210 Disposed 2024-04-02 Common Stock (210) Direct
2021-12-14 Non Qualified Stock Option $203.54 X 532 Disposed 2025-06-10 Common Stock (532) Direct
2021-12-14 Non Qualified Stock Option $226.72 X 917 Disposed 2026-06-15 Common Stock (917) Direct

Footnotes

F1: 1/5 exercisable on each anniversary date of the 04-02-2018 grant date

F2: 1/4 exercisable on each anniversary date of the 06-10-2019 grant date

F3: 1/3 exercisable on each anniversary date of the 06-15-2020 grant date